Company intelligence / Profile preview

Cyrcadia Health

Ownership: Private
Development stage: Other

Overview

Cyrcadia Health has developed a wearable, non-invasive device that monitors circadian temperature changes in breast tissue to assist with early detection of abnormal patterns associated with breast cancer. The system uses machine learning algorithms to analyze data and provide automated results to healthcare providers. Clinical results are not detailed publicly, but the technology aims to improve early identification and monitoring of breast health.

Therapeutic areas: Women's HealthOncology
Modalities: DeviceWearable technology
Industry: Physiological Monitoring

Partnerships

Nanyang Technological University of Singapore (technology development partner)

Beyond the preview

Go deeper on Cyrcadia Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyrcadia Health.

Explore the full profile